GlassScriptPhysician profile
Timothy J Shoemaker
NPI 1871751461
$3,064.86
in general payments reported to CMS, 2019-2025
23 companies · $76.43 in 2025
The $76.43 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,234 · 2020: $539 · 2021: $511 · 2022: $628 · 2023: $76.50 · 2025: $76.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $152.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,067.38 | 2019-2023 | Farxiga |
| Novo Nordisk INC | $657.71 | 2019-2023 | Rybelsus, Ozempic |
| Sanofi-Aventis U.S. LLC | $263.40 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $147.12 | 2019-2023 | Verquvo, Steglatro |
| Shire North American Group INC | $115.37 | 2019 | |
| Amgen INC. | $93.41 | 2019-2022 | |
| Mannkind Corporation | $89.21 | 2019 | |
| Medtronic, INC. | $76.43 | 2025 | Minimed 780g |
| Abbott Laboratories | $74.87 | 2019-2022 | |
| Antares Pharma, INC. | $74.47 | 2021-2022 | |
| Lilly USA, LLC | $71.37 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.37 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $50.72 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $41.77 | 2021-2022 | |
| Insulet Corporation | $40.28 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $37.00 | 2019-2020 | |
| Amarin Pharma, INC. | $24.85 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.37 | 2019 | |
| Companion Medical, INC. | $18.29 | 2019 | |
| Senseonics, Incorporated | $16.00 | 2019 | |
| Medtronic Minimed, INC. | $13.58 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $12.14 | 2022 | |
| Clarus Therapeutics INC. | $5.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Shoemaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.